Bank of New York Mellon
BMY.RT

Bank of New York Mellon’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bank of New York Mellon’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-68,029
Closed -$46K – 4410
2020
Q4 		$46K Sell
68,029
-132,033
-66% -$281K ﹤0.01% 4158
2020
Q3 		$449K Sell
200,062
-49,666
-20% -$142K ﹤0.01% 3549
2020
Q2 		$893K Sell
249,728
-63,538
-20% -$229K ﹤0.01% 3170
2020
Q1 		$1.19M Sell
313,266
-54,258
-15% -$179K ﹤0.01% 2851
2019
Q4 		$1.11M Buy
+367,524
New +$956K ﹤0.01% 3192

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Bank of New York Mellon's BMY.RT Position: Q1 2021 in Review

Bank of New York Mellon sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 68,029 shares — an estimated $46K sold.

Bank of New York Mellon first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.19M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Bank of New York Mellon reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 68,029 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $46K.
  • Bank of New York Mellon first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Bank of New York Mellon's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.19M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.